Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole vs. Amphotericin B for Invasive Aspergillosis
NCT00001646Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in invasive aspergillosis (IA), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 1997; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00001646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001646.